• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪组织 ATF3 的缺失促进脂肪组织脂解和 MASH 的发展。

Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH.

机构信息

Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, 44272, USA.

Department of Internal Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, 85004, USA.

出版信息

Commun Biol. 2024 Oct 10;7(1):1300. doi: 10.1038/s42003-024-06915-x.

DOI:10.1038/s42003-024-06915-x
PMID:39390075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11467330/
Abstract

The crosstalk between adipose tissue and the liver is finely controlled to maintain metabolic health. Yet, how adipose tissue controls toxic free fatty acid overflow into the liver remains incompletely understood. Here, we show that adipocyte activating transcription factor 3 (ATF3) was induced in human or mouse obesity. Adipocyte Atf3 (Atf3) mice developed obesity, glucose intolerance, and metabolic dysfunction-associated steatohepatitis (MASH) in chow diet, high-fat diet, or Western diet-fed mice. Blocking fatty acid flux by inhibiting hepatocyte CD36, but not the restoration of hepatic AMPK signaling, prevented the aggravation of MASH in Atf3 mice. Further studies show that the loss of adipocyte ATF3 increased lipolysis via inducing adipose triglyceride lipase, which in turn induced lipogenesis and inflammation in hepatocytes. Moreover, Atf3 mice had reduced energy expenditure and increased adipose lipogenesis and inflammation. Our data demonstrate that adipocyte ATF3 is a gatekeeper in counteracting MASH development under physiological and pathological conditions.

摘要

脂肪组织和肝脏之间的串扰受到精细调控,以维持代谢健康。然而,脂肪组织如何控制有毒游离脂肪酸溢出到肝脏仍不完全清楚。在这里,我们表明脂肪细胞激活转录因子 3 (ATF3) 在人类或小鼠肥胖中被诱导。脂肪细胞 Atf3 (Atf3) 小鼠在 Chow 饮食、高脂肪饮食或西方饮食喂养的小鼠中发展为肥胖、葡萄糖不耐受和代谢功能障碍相关的脂肪性肝炎 (MASH)。通过抑制肝细胞 CD36 阻断脂肪酸通量,而不是恢复肝 AMPK 信号,可防止 Atf3 小鼠 MASH 的恶化。进一步的研究表明,脂肪细胞 ATF3 的缺失通过诱导脂肪甘油三酯脂肪酶增加脂肪分解,进而诱导肝细胞的脂肪生成和炎症。此外,Atf3 小鼠的能量消耗减少,脂肪组织的脂肪生成和炎症增加。我们的数据表明,脂肪细胞 ATF3 是在生理和病理条件下对抗 MASH 发展的守门员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/1c5f7c1caec2/42003_2024_6915_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/3b088fd28647/42003_2024_6915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/03cffe5ba05a/42003_2024_6915_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/9b857bca6f03/42003_2024_6915_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/dbf56d942e61/42003_2024_6915_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/47137907a858/42003_2024_6915_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/cfdd3ffe0843/42003_2024_6915_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/47372f3ab0d0/42003_2024_6915_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/e3df80e75605/42003_2024_6915_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/1c5f7c1caec2/42003_2024_6915_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/3b088fd28647/42003_2024_6915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/03cffe5ba05a/42003_2024_6915_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/9b857bca6f03/42003_2024_6915_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/dbf56d942e61/42003_2024_6915_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/47137907a858/42003_2024_6915_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/cfdd3ffe0843/42003_2024_6915_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/47372f3ab0d0/42003_2024_6915_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/e3df80e75605/42003_2024_6915_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93f9/11467330/1c5f7c1caec2/42003_2024_6915_Fig9_HTML.jpg

相似文献

1
Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH.脂肪组织 ATF3 的缺失促进脂肪组织脂解和 MASH 的发展。
Commun Biol. 2024 Oct 10;7(1):1300. doi: 10.1038/s42003-024-06915-x.
2
Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction-associated steatohepatitis.肝巨噬细胞中由激活转录因子3(Atf3)介导的代谢重编程引发代谢功能障碍相关的脂肪性肝炎。
Sci Adv. 2024 Jul 26;10(30):eado3141. doi: 10.1126/sciadv.ado3141. Epub 2024 Jul 24.
3
Lack of Gα proteins in adipocytes attenuates diet-induced obesity.脂肪细胞中 Gα 蛋白的缺乏会减弱饮食诱导的肥胖。
Mol Metab. 2020 Oct;40:101029. doi: 10.1016/j.molmet.2020.101029. Epub 2020 May 30.
4
Adipocyte retinoic acid receptor α prevents obesity and steatohepatitis by regulating energy expenditure and lipogenesis.脂肪细胞视黄酸受体 α 通过调节能量消耗和脂肪生成预防肥胖和脂肪性肝炎。
Obesity (Silver Spring). 2024 Jan;32(1):120-130. doi: 10.1002/oby.23929. Epub 2023 Oct 24.
5
Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3.脂肪细胞棕色化和小鼠肥胖抵抗由 ATF3 的表达诱导。
Commun Biol. 2019 Oct 24;2:389. doi: 10.1038/s42003-019-0624-y. eCollection 2019.
6
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver.脂肪细胞 PHBPP2 抑制可预防肥胖诱导的脂肪肝。
Nat Commun. 2021 Mar 23;12(1):1822. doi: 10.1038/s41467-021-22106-2.
7
Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.小鼠中人类肝脂肪酶的过表达通过促进肝脏脂肪生成、白色脂肪组织脂肪分解和脂肪酸摄取,诱导肝脂肪变性和肥胖。
PLoS One. 2017 Dec 15;12(12):e0189834. doi: 10.1371/journal.pone.0189834. eCollection 2017.
8
The ATF3 inducer protects against diet-induced obesity via suppressing adipocyte adipogenesis and promoting lipolysis and browning.ATF3诱导剂通过抑制脂肪细胞脂肪生成、促进脂肪分解和褐色化来预防饮食诱导的肥胖。
Biomed Pharmacother. 2022 Jan;145:112440. doi: 10.1016/j.biopha.2021.112440. Epub 2021 Nov 25.
9
Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.肠系膜脂肪脂解介导肥胖相关的肝脂肪变性和胰岛素抵抗。
Diabetes. 2016 Jan;65(1):140-8. doi: 10.2337/db15-0941. Epub 2015 Sep 17.
10
Adipocyte-specific Hypoxia-inducible gene 2 promotes fat deposition and diet-induced insulin resistance.脂肪细胞特异性缺氧诱导因子 2 促进脂肪沉积和饮食诱导的胰岛素抵抗。
Mol Metab. 2016 Sep 28;5(12):1149-1161. doi: 10.1016/j.molmet.2016.09.009. eCollection 2016 Dec.

引用本文的文献

1
Separable cryo-microneedle patches delivery with capsaicin integrated mesoporous dopamine for obesity treatment.用于肥胖治疗的含辣椒素的介孔多巴胺可分离式冷冻微针贴片递送
J Nanobiotechnology. 2025 Sep 3;23(1):604. doi: 10.1186/s12951-025-03645-y.
2
Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease.心脏代谢指数作为代谢功能障碍相关脂肪性肝病死亡率的预测指标。
BMC Gastroenterol. 2025 Jul 29;25(1):537. doi: 10.1186/s12876-025-04127-z.

本文引用的文献

1
Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature.回复:关于新的脂肪性肝病命名的多学会德尔菲共识声明。
Hepatology. 2024 Mar 1;79(3):E93-E94. doi: 10.1097/HEP.0000000000000696. Epub 2023 Nov 20.
2
Adipocyte retinoic acid receptor α prevents obesity and steatohepatitis by regulating energy expenditure and lipogenesis.脂肪细胞视黄酸受体 α 通过调节能量消耗和脂肪生成预防肥胖和脂肪性肝炎。
Obesity (Silver Spring). 2024 Jan;32(1):120-130. doi: 10.1002/oby.23929. Epub 2023 Oct 24.
3
Protocol for assessing ex vivo lipolysis of murine adipose tissue.
评估鼠脂肪组织体外脂肪分解的方案。
STAR Protoc. 2022 Sep 16;3(3):101518. doi: 10.1016/j.xpro.2022.101518. Epub 2022 Jul 1.
4
Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.脂肪组织功能障碍及其在非酒精性脂肪性肝病发病机制中的作用的最新进展。
Cells. 2021 Nov 25;10(12):3300. doi: 10.3390/cells10123300.
5
The ATF3 inducer protects against diet-induced obesity via suppressing adipocyte adipogenesis and promoting lipolysis and browning.ATF3诱导剂通过抑制脂肪细胞脂肪生成、促进脂肪分解和褐色化来预防饮食诱导的肥胖。
Biomed Pharmacother. 2022 Jan;145:112440. doi: 10.1016/j.biopha.2021.112440. Epub 2021 Nov 25.
6
Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α.肝细胞激活转录因子 3 通过肝细胞核因子 4α 保护抵抗脂肪性肝炎。
Diabetes. 2021 Nov;70(11):2506-2517. doi: 10.2337/db21-0181. Epub 2021 Sep 2.
7
Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.肝细胞激活转录因子 3 通过调节高密度脂蛋白和胆汁酸代谢来保护动脉粥样硬化。
Nat Metab. 2021 Jan;3(1):59-74. doi: 10.1038/s42255-020-00331-1. Epub 2021 Jan 18.
8
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病相关肝细胞癌的全球流行病学:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
9
Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).肝细胞核因子 4α 通过调节 p53 和胆汁酸信号转导预防脂肪变性向 NASH 进展(在小鼠中)。
Hepatology. 2021 Jun;73(6):2251-2265. doi: 10.1002/hep.31604. Epub 2021 May 14.
10
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?理解非酒精性脂肪性肝病发病机制中的脂毒性:CD36 是关键驱动因素吗?
Cell Death Dis. 2020 Sep 25;11(9):802. doi: 10.1038/s41419-020-03003-w.